Pfizer Inc. (PFE)
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
The company's latest institutional shareholder has made some troubling allegations against it.
Pfizer battles activist fund Starboard, which has a $1 billion stake in company
CNBC Angelica Peebles joins 'Power Lunch' to report on Pfizer's activist battle.
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Pfizer (PFE) shares lost ground Thursday after two former executives released a statement supporting the company's current management after activist investor Starboard Value this week took a $1 billion stake in the struggling drug maker and moved to make changes.
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Starboard seeks probe after former Pfizer execs pull support for its campaign
Starboard Value has asked Pfizer to set up a special committee to investigate allegations that two of its former senior executives were forced to publicly declare support for CEO Albert Bourla, the hedge fund said on Thursday.
Pfizer Skids After Former Execs Flip On Activist Investor, Siding With CEO Albert Bourla
Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
Activist Starboard Value accused Pfizer of threatening litigation against two renegade former executives that initially were supportive of the investor's turnaround campaign at the pharmaceutical giant. Starboard's Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as "flagrantly unethical.
Pfizer's stock dips after two former execs say they won't support Starboard, offer backing for CEO Albert Bourla
Pfizer Inc.'s stock dipped early Thursday, after two of its former executives said they would not support an effort by activist shareholder Starboard Value to orchestrate a turnaround.
Pfizer's cancer drug combo improves overall survival in late-stage study
Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of advanced prostate cancer in a late-stage study.
2 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Both of these stocks should have plenty of room to run.
Former Pfizer executives not involved in Starboard's campaign against drugmaker
Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with activist investor Starboard Value, which wants the U.S. drug giant to make changes to turn its performance around.
